Tonghua Dongbao Pharmaceutical Co Ltd Total Liabilities
Tonghua Dongbao Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has total liabilities worth CN¥1.01 Billion CNY (≈ $148.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Tonghua Dongbao Pharmaceutical Co Ltd (600867) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Tonghua Dongbao Pharmaceutical Co Ltd (1994–2025)
Total liabilities of Tonghua Dongbao Pharmaceutical Co Ltd from 1994 to 2025. This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 600867 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningbo Jintian Copper Group Co Ltd
SHG:601609
|
China | CN¥18.37 Billion |
|
Compagnie Financiere Tradition
SW:CFT
|
Switzerland | CHF648.95 Million |
|
Pertamina Geothermal Energy
JK:PGEO
|
Indonesia | Rp952.10 Million |
|
Ternium Argentina SA
BA:TXAR
|
Argentina | AR$783.28 Billion |
|
Data Patterns (India) Limited
NSE:DATAPATTNS
|
India | Rs2.15 Billion |
|
Douzone Bizon Co Ltd
KO:012510
|
Korea | ₩517.29 Billion |
|
Shanghai Flyco Electrical Appliance Co Ltd
SHG:603868
|
China | CN¥624.18 Million |
|
NBCC (India) Limited
NSE:NBCC
|
India | Rs105.40 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Tonghua Dongbao Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 600867 total asset value.
Liquidity & Leverage Metrics
Tonghua Dongbao Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Tonghua Dongbao Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tonghua Dongbao Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tonghua Dongbao Pharmaceutical Co Ltd (1994–2025)
The table below shows the annual total liabilities of Tonghua Dongbao Pharmaceutical Co Ltd from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥798.84 Million ≈ $116.90 Million |
-18.33% |
| 2024-12-31 | CN¥978.08 Million ≈ $143.12 Million |
+76.21% |
| 2023-12-31 | CN¥555.08 Million ≈ $81.23 Million |
+176.52% |
| 2022-12-31 | CN¥200.74 Million ≈ $29.37 Million |
-33.06% |
| 2021-12-31 | CN¥299.87 Million ≈ $43.88 Million |
+23.00% |
| 2020-12-31 | CN¥243.80 Million ≈ $35.68 Million |
-28.52% |
| 2019-12-31 | CN¥341.10 Million ≈ $49.91 Million |
-53.21% |
| 2018-12-31 | CN¥729.06 Million ≈ $106.68 Million |
+238.63% |
| 2017-12-31 | CN¥215.30 Million ≈ $31.50 Million |
-70.50% |
| 2016-12-31 | CN¥729.76 Million ≈ $106.79 Million |
-44.26% |
| 2015-12-31 | CN¥1.31 Billion ≈ $191.56 Million |
+64.52% |
| 2014-12-31 | CN¥795.72 Million ≈ $116.44 Million |
+17.32% |
| 2013-12-31 | CN¥678.23 Million ≈ $99.25 Million |
+74.39% |
| 2012-12-31 | CN¥388.92 Million ≈ $56.91 Million |
+29.91% |
| 2011-12-31 | CN¥299.37 Million ≈ $43.81 Million |
-34.02% |
| 2010-12-31 | CN¥453.75 Million ≈ $66.40 Million |
-27.37% |
| 2009-12-31 | CN¥624.75 Million ≈ $91.42 Million |
-15.31% |
| 2008-12-31 | CN¥737.66 Million ≈ $107.94 Million |
+0.37% |
| 2007-12-31 | CN¥734.97 Million ≈ $107.55 Million |
+6.34% |
| 2006-12-31 | CN¥691.13 Million ≈ $101.13 Million |
+26.99% |
| 2005-12-31 | CN¥544.23 Million ≈ $79.64 Million |
+13.35% |
| 2004-12-31 | CN¥480.12 Million ≈ $70.26 Million |
+21.87% |
| 2003-12-31 | CN¥393.95 Million ≈ $57.65 Million |
+91.68% |
| 2002-12-31 | CN¥205.52 Million ≈ $30.07 Million |
+163.62% |
| 2001-12-31 | CN¥77.96 Million ≈ $11.41 Million |
+76.76% |
| 2000-12-31 | CN¥44.10 Million ≈ $6.45 Million |
-52.47% |
| 1999-12-31 | CN¥92.79 Million ≈ $13.58 Million |
-62.86% |
| 1998-12-31 | CN¥249.82 Million ≈ $36.56 Million |
+286.09% |
| 1997-12-31 | CN¥64.70 Million ≈ $9.47 Million |
+25.51% |
| 1996-12-31 | CN¥51.55 Million ≈ $7.54 Million |
-30.22% |
| 1995-12-31 | CN¥73.88 Million ≈ $10.81 Million |
+213.84% |
| 1994-12-31 | CN¥23.54 Million ≈ $3.44 Million |
-- |
About Tonghua Dongbao Pharmaceutical Co Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more